https://www.newswire.ca/news-releases/merck-kgaa-darmstadt-germany-decides-not-to-pursue-evofosfamide-further-in-soft-tissue-sarcoma-and-pancreatic-cancer-560761541.html
Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma...
/CNW/ - Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it is not planning to file for approval of...